Sandoz Group AG (SWX:SDZ)
67.78
-0.82 (-1.20%)
Jul 10, 2026, 5:30 PM CET
Sandoz Group AG Revenue
In the year 2025, Sandoz Group AG had annual revenue of $11.16B USD with 7.44% growth. Sandoz Group AG had revenue of $5.89B in the half year ending December 31, 2025, with 16.70% growth.
Revenue
$11.16B
Revenue Growth
+7.44%
P/S Ratio
3.32
Revenue / Employee
$499.06K
Employees
22,356
Market Cap
29.33B CHF
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.16B | 773.00M | 7.44% |
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 45.38B |
| Alcon | 8.53B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Galenica AG | 4.15B |
| Sonova Holding AG | 3.61B |
| Straumann Holding AG | 2.61B |
Sandoz Group AG News
- 13 days ago - Sandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide - TheFly
- 13 days ago - FDA set to review Sandoz's generic GLP-1s - Reuters
- 6 weeks ago - Generic drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics imports - Reuters
- 2 months ago - Sandoz confirms the EC granted marketing authorization for Bysumlog, Dazparda - TheFly
- 2 months ago - Sandoz CEO Says Size of Weight-Loss Generics Market Is Unknown - WSJ
- 2 months ago - Sandoz upgraded to Overweight from Equal Weight at Barclays - TheFly
- 2 months ago - Sandoz price target lowered to CHF 65 from CHF 70 at Deutsche Bank - TheFly
- 2 months ago - Sandoz Group AG Earnings Call Transcript: Q1 2026 - Transcripts